568
Views
8
CrossRef citations to date
0
Altmetric
Reviews

An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer

& , MD, PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Siqing Fu, Yudong Wang, Khandan Keyomarsi & Funda Meric-Bernstein. (2018) Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy. Expert Opinion on Investigational Drugs 27:9, pages 741-751.
Read now

Articles from other publishers (7)

Emma Baglini, Lorenzo Chiaverini, Iogann Tolbatov, Sabrina Taliani, Federico Da Settimo, Diego La Mendola, Elisabetta Barresi & Tiziano Marzo. (2023) Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity—a perspective overview. BioMetals.
Crossref
Abhishek Chatterjee, Vineet Kumar Mishra, Susmita Saha & Snehasikta Swarnakar. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2635 2656 .
Abhishek Chatterjee, Vineet Kumar Mishra, Susmita Saha & Snehasikta Swarnakar. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 1 22 .
Francesca Roggiani, Cristina Riva, Francesco Raspagliesi, Giovanni Porta, Roberto Valli, Roberto Taramelli, Francesco Acquati, Delia Mezzanzanica & Antonella Tomassetti. (2019) A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling. Cancers 11:2, pages 255.
Crossref
Rishil J. Kathawala, Andrzej Kudelka & Basil Rigas. (2018) The Chemoprevention of Ovarian Cancer: the Need and the Options. Current Pharmacology Reports 4:3, pages 250-260.
Crossref
Ozlen SaglamYin XiongDouglas C. MarchionCarolina StrosbergRobert M. WenhamJoseph J. JohnsonDaryoush Saeed-VafaChristopher CubittArdeshir HakamAnthony M. Magliocco. (2018) ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy. Cancer Control 24:1, pages 89-95.
Crossref
Qin Yan, Fangyuan Wang, Yi Miao, Xiaomei Wu, Mingzhu Bai, Xiaowei Xi & Youji Feng. (2016) Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase. Tumor Biology 37:9, pages 12263-12271.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.